4026 — Konoshima Chemical Co Balance Sheet
0.000.00%
- ¥13bn
- ¥22bn
- ¥27bn
- 58
- 83
- 47
- 72
Annual balance sheet for Konoshima Chemical Co, fiscal year end - April 30th, JPY millions except per share, conversion factor applied.
2021 April 30th | 2022 April 30th | 2023 April 30th | 2024 April 30th | 2025 April 30th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
| Standards: | JAS | JAS | JAS | JAS | JAS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 967 | 1,871 | 2,148 | 1,174 | 1,439 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 4,001 | 4,989 | 5,464 | 5,000 | 5,050 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 8,383 | 11,096 | 12,814 | 11,437 | 11,806 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 8,872 | 12,266 | 15,301 | 16,946 | 17,165 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 18,602 | 24,697 | 29,389 | 29,747 | 30,731 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 7,090 | 11,188 | 14,259 | 12,382 | 13,493 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 10,062 | 15,332 | 18,831 | 17,838 | 17,767 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 8,540 | 9,365 | 10,558 | 11,909 | 12,964 |
| Total Liabilities & Shareholders' Equity | 18,602 | 24,697 | 29,389 | 29,747 | 30,731 |
| Total Common Shares Outstanding |